Periodic monitoring Active

Key facts

  • In May 2024, 26 countries reported measles data to The European Surveillance System (TESSy), with 672 cases reported by 18 countries. Eight countries reported zero cases.
  • Through its epidemic intelligence activities, ECDC has identified 3 010 new measles cases in 19 EU/EEA countries that were not reported before the last monthly update.
  • In 2024, 19 measles-related deaths have been reported in Romania (18) and Ireland (1).
  • Overall, measles transmission in the EU/EEA has been increasing over the last 12 months, although the situation varies by country, with some countries reporting large outbreaks and others sustaining no or very low transmission.
  • Relevant updates outside the EU/EEA are available for Switzerland, the UK, and countries in the Western Balkan and WHO Regions.

Overview

In May 2024, 26 countries reported measles data to The European Surveillance System (TESSy), with 672 cases reported by 18 countries. Eight countries reported zero cases.

In the most recent 12-month period, from 1 June 2023 to 31 May 2024, 30 EU/EEA Member States reported 6 742 measles cases, 5 778 (85.7%) of which were laboratory-confirmed. During this 12-month period, two countries (Latvia and Luxembourg) reported zero cases. The highest number of cases were reported by Romania (4 115), Italy (597), Austria (510), France (395), and Belgium (320). The highest notification rates were observed among infants under one year of age (186.5 cases per million) and children aged 1-4 years (119.7 cases per million). Four deaths attributable to measles were reported to ECDC during the 12-month period by Romania (three) and Ireland (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases and the Measles and Rubella monthly report.

Complementary epidemic intelligence surveillance with data collection conducted between 8 and 11 July 2024 from official public and media sources detected 3 010 new suspected and/or confirmed measles cases, including three new deaths, that were not reported before the last monthly update. New cases were reported in 19 EU/EEA countries in recent months: Austria (new: 18, total: 464), Belgium (new: 177, total: 265), Bulgaria (new: 10, total: 17), Cyprus (new: 2, total: 24), Czechia (new: 1, total: 29), Denmark (new: 1, total: 19), France (new: 3, total: 168), Germany (new: 57, total: 390), Greece (new: 6, total: 29), Ireland (new: 17, total: 69, including 1 death), Italy (new: 157, total: 556), Lithuania (new: 1, total: 26), Netherlands (new: 25, total: 105), Norway (new: 3, total: 6), Poland (new: 31, total: 222), Romania (new: 2 392 cases, three deaths, total: 17 733, including 18 deaths), Slovenia (new: 13, total: 16), Spain (new: 90, total: 161), Sweden (new: 7, total: 21).

Overall, 19 measles-related deaths have been reported in the EU/EEA in 2024, in Romania (18) and in Ireland (1).

Relevant updates for outside the EU/EEA are available for Switzerland, the UK, and countries in the Western Balkan and WHO Regions.

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with epidemic intelligence updates since last month:

Austria reported 464 confirmed measles cases in 2024 as of 09 July 2024, an increase of 18 cases since 11 June 2024. Of the 455 cases for which hospitalisation information was available, 95 individuals (21%) were hospitalised, including four in the intensive care unit. All regions reported at least one case of measles in 2024, with most of the cases reported in Lower Austria (113, 24%) and Tyrol (87, 19%).

 

Belgium reported 265 confirmed measles cases in TESSy between January to May 2024 and as of 10 July 2024, an increase of 177 cases since 12 June 2024.

Bulgaria reported 17 cases in 2024 and as of 8 July 2024, an increase of 10 cases since the last monthly update. No cases were reported for the same period of the previous year.

Cyprus reported 24 confirmed measles cases between February and May 2024 (as of 10 July June 2024) to ECDC, an increase of one case since the previous monthly report.

Czechia reported 29 cases in January to June 2024, including one case since May.

Denmark reported 19 cases in 2024 and as of 9 July, an increase by one case since the monthly update on 12 June. Among all reported cases, four (21%) were children below 15 years, and 13 (68%) were adults aged 25-54 years.

France reported no new confirmed measles cases since the last monthly update. As of 25 June, 98 cases associated with the outbreak in Rin Rhône, in Auvergne-Rhône-Alpes region were reported, an increase of three since 4 June.

Germany reported 390 confirmed and suspected measles cases in 2024 (data as of 10 July 2024), an increase of 57 cases since 10 June 2024.

Greece reported 29 measles cases to TESSy between 1 January and May 2024 as of 11 July, an increase of six cases since the last monthly update.

Ireland has reported 69 confirmed measles cases as of 9 July 2024, an increase of 17 cases since the last monthly update on 12 June 2024. In addition, 15 cases are currently under investigation. Outbreaks have been reported across all six Health Service Executive (HSE) regions.

 

Italy reported 556 measles cases (493 confirmed) between 1 January and 31 May 2024 and as of 11 June 2024. This is an increase of 157 since 15 May 2024. Cases have been reported from 17/21 regions, with 61% of cases reported from regions Lazio, Emilia-Romagna, Sicily and Tuscany. The highest incidence was observed in the Abruzzo region (73.7.1 per million), followed by Lazio (61.0 per million) and Emilia-Romagna (52.6 per million). At a national level, the incidence in this period was 22.7 cases per million inhabitants. Over half of the cases (53%) are aged between 15 and 39 years, and 22% are over 40. The highest incidence was observed in the 0-4 age group (87.5 cases per million), followed by 15–39-year-olds (46 cases per million). Among 531 cases with known vaccination status, 476 cases (90%) were not vaccinated.

 

Lithuania has reported 26 cases in 2024 as of 21 June 2024, an increase of one case since 6 June 2024. Of the reported cases, 73% were unvaccinated, 15% were fully vaccinated, and 12% had incomplete vaccination; overall, 40% of cases required hospitalisation.

 

Netherlands reported 105 cases of measles in 2024 and as of 26 June 2024, an increase of 25 cases since 29 May 2024. Recent media reports include report of a large measles outbreak in a primary school in The Hague.

 

Norway reported six cases as of 9 July 2024, an increase of three since 12 June 2024.

Poland reported 222 cases of measles from January to 30 June 2024, an increase of 31 cases since 31 May 2024. From January-May 2024, 185 confirmed cases were reported to TESSy.

Romania has reported 17 733 cases, including 18 deaths, from January to 7 July 2024, an increase of 2 392 cases and three deaths since 9 June 2024. This nationwide outbreak started in 2023, and 20 538 confirmed measles cases, including 21 deaths, have been reported from 1 January 2023 to 7 July 2024. The cases have been reported in all 41 counties and the Municipality of Bucharest. The highest incidence of measles continues to be reported in Braşov (380.8 cases per 100 000 population), followed by Alba, Giurgiu, and Mureş counties (279.2, 244.6 and 240.1 cases per 100 000 population, respectively). Children aged 0-9 years account for 66.3% (13 624) of all reported cases, including 2 830 children under one year (13.8%). Among cases with known vaccination status (18 255), unvaccinated individuals across all age groups accounted for 90.4%.

 

Slovenia reported 16 measles cases between January and June 2024 and as of 4 July 2024. This is an increase of 13 cases since the monthly update in week 11.

Spain reported 161 measles cases from 1 January to 7 July 2024, an increase of 90 cases since 2 June 2024. Of these, 28 cases were imported.

Sweden has reported 21 cases

Relevant epidemiological summary for countries outside the EU/EEA:

Switzerland has reported 90 cases in 2024 as of 9 July 2024, an increase of 3 cases since 3 June 2024.

United Kingdom has reported several outbreaks of measles in 2024. Since the last monthly update, 727 measles cases were notified in England and Wales between weeks 23-26 and as of 30 June 2024. As of 4 July, 1 936 measles cases have been confirmed in England in 2024. In Northern Ireland 11 cases were confirmed in 2024 and as of 30 June 2024. In Scotland, there have been 14 laboratory-confirmed measles cases in 2024 and as of 10 July 2024.

Western Balkan: Several countries continue to report reported increased measles cases this year.

Bosnia and Herzegovina has reported the highest number of measles cases. The Republic of Srpska has reported 251 measles cases as of 5 July 2024, an increase of 57 cases since 7 June 2024. Most cases were in the age group 1-4 years (104 cases, 41%). The city of Bijeljina contributed 72% of the confirmed cases. In the weeks 1-27 of 2024, the Federation of Bosnia and Herzegovina notified 6 232 measles cases, an increase of 1 699 cases since the last monthly report in week 22. Most notified cases are in the age group 1-4 years (2 167, 35 %). Of all notified cases, 5 344 (86%) were unvaccinated.

 

Serbia reported 181 measles cases as of 7 July 2024, an increase by 62 cases since 2 June 2024. Outbreaks have been reported throughout the country.

Montenegro has reported the first case of measles on 28 March 2024. As of 5 July 2024, seven measles cases have been reported.

Summary for WHO regional offices

WHO Regional Office for the Americas (WHO PAHO) has reported 253 confirmed measles cases in 2024 as of 29 June 2024. Cases have been reported from eight countries: Argentina (3), Bolivia (2), Brazil (1), Canada (77), Caribbeans (2), Peru (2), the United States of America (159), and Mexico (7).

For the other WHO Regions the most recent data were published as of 10 June 2024. These data were presented also in the previous update.

WHO Regional Office for Europe (WHO/EUROPE) reported 70 879 measles cases in 2024 as of 10 June 2024. The five non-EU/EEA countries reporting the most measles cases: Kazakhstan (24 702), Azerbaijan (16 122), Russia (10 051), Kyrgyzstan (9 011), and United Kingdom (914).

The numbers provided to WHO for EU/EEA countries are from TESSy data, updated monthly and available on ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting time the numbers may not correspond to the data from epidemic intelligence screening.

WHO Regional Office for Africa (WHO AFRO) has reported 44 366 measles cases in 2024 as of 10 June 2024. As of 29 May 2024*, measles cases and outbreaks were reported in the following countries in 2024: Burkina Faso, Burundi, Cameroon, Chad, Congo, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Kenya, Liberia, Mali, Mauritania, Niger, Nigeria, Senegal, South Sudan, Togo, Uganda, and Zambia.

*As reporting periods vary by country, please check the latest available weekly bulletin.

WHO Regional Office for the Eastern Mediterranean (WHO EMRO) has reported 41 568 measles cases in 2024 as of 10 June 2024. The highest number of cases was reported from Iraq (24 208), Yemen (7 307), Pakistan (4 826), Afghanistan (3 744) and the United Arab Emirates (830).

WHO Regional Office for South-East Asia (WHO SEARO) has reported 16 349 measles cases in 2024 as of 10 June 2024. The highest number of cases was reported from India (13 618), Indonesia (1 392), Thailand (919), Sri Lanka (158), and Nepal (133).

WHO Regional Office for the Western Pacific (WHO WPRO) has reported 5 074 measles cases in 2024 as of 10 June 2024. Nine countries reported cases: the Philippines (2 655), Malaysia (2 008), China (219), Vietnam (90), the Republic of Korea (39), Australia (31), Japan (21), Singapore (7), and Cambodia (4).

ECDC assessment

The overall number of measles cases in the EU/EEA has been steadily increasing since June 2023. Measles cases are expected to continue increasing in the EU/EEA in the coming months due to reported sub-optimal vaccination coverage for measles- containing vaccines (MCV) in a number of EU/EEA countries (<95% in a many of these countries), the high probability of importation from areas experiencing high circulation. In addition, the recent report of a majority of cases having acquired the disease within the reported country through community/local transmission, indicates a higher probability of being exposed to the virus within the EU/EEA than in previous months.

As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local/national authorities).
  • Strive towards high-quality surveillance, and adequate public health capacity, especially for early detection, diagnosis, response, and control of outbreaks.
  • Increase the clinical awareness of health professionals.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of sub-optimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with underserved populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies, to reduce inequalities in vaccine uptake.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response' published in February 2024 and the conclusions of that remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.  

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries. ECDC's latest advice on measles is available in the Threat Assessment Brief, 'Measles on the rise in the EU/EEA: Considerations for a public health response', published on 15 February 2024.

Latest updates for this event

View all